Healthcare provider profile · identity verified

Sarah Sam Olelewe, M.D.

Geriatric Medicine · HAWTHORNE, CA · NPI 1689754665

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	564	154
Atorvastatin Calcium	Atorvastatin Calcium	411	115
Montelukast Sodium	Montelukast Sodium	362	132
Levothyroxine Sodium	Levothyroxine Sodium	245	49
Meloxicam	Meloxicam	229	69
Rosuvastatin Calcium	Rosuvastatin Calcium	221	63
Losartan Potassium	Losartan Potassium	183	54
Pantoprazole Sodium	Pantoprazole Sodium	167	59
Potassium Chloride	Potassium Chloride	162	49
Famotidine	Famotidine	146	41
Metoprolol Tartrate	Metoprolol Tartrate	146	32
Furosemide	Furosemide	131	43
Jardiance	Empagliflozin	131	26
Metformin Hcl	Metformin Hcl	131	46
Hydralazine Hcl	Hydralazine Hcl	125	37
Diclofenac Sodium	Diclofenac Sodium	123	49
Clopidogrel	Clopidogrel Bisulfate	115	34
Gabapentin	Gabapentin	115	41
Omeprazole	Omeprazole	112	28
Eliquis	Apixaban	111	30
Fluticasone Propionate	Fluticasone Propionate	108	36
Januvia	Sitagliptin Phosphate	107	28
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	104	32
Azithromycin	Azithromycin	103	92
Glimepiride	Glimepiride	101	30
Albuterol Sulfate Hfa	Albuterol Sulfate	100	30
Lisinopril	Lisinopril	96	22
Simvastatin	Simvastatin	94	25
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	91	suppressed
Tramadol Hcl	Tramadol Hcl	89	28
Metoprolol Succinate	Metoprolol Succinate	88	26
Linzess	Linaclotide	87	34
Pregabalin	Pregabalin	87	32
Atenolol	Atenolol	86	27
Glipizide	Glipizide	85	21
Triamcinolone Acetonide	Triamcinolone Acetonide	79	42
Mirtazapine	Mirtazapine	78	16
Donepezil Hcl	Donepezil Hcl	71	15
Latanoprost	Latanoprost	71	11
Tamsulosin Hcl	Tamsulosin Hcl	70	23
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	67	14
Mounjaro	Tirzepatide	66	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	65	27
Duloxetine Hcl	Duloxetine Hcl	63	18
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	60	14
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	57	22
Memantine Hcl	Memantine Hcl	56	11
Acetaminophen-Codeine	Acetaminophen With Codeine	54	19
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	54	25
Lidocaine	Lidocaine	54	28
Hydrochlorothiazide	Hydrochlorothiazide	53	18
Olmesartan-Amlodipine-Hctz	Olmesartan/Amlodipin/Hcthiazid	53	13
Nifedipine Er	Nifedipine	48	13
Galantamine Er	Galantamine Hbr	47	14
Levofloxacin	Levofloxacin	46	39
Metformin Hcl Er	Metformin Hcl	46	15
Carvedilol	Carvedilol	45	14
Metolazone	Metolazone	45	11
Ozempic	Semaglutide	43	15
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	43	33
Benazepril Hcl	Benazepril Hcl	42	11
Levetiracetam	Levetiracetam	42	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	40	11
Allopurinol	Allopurinol	39	11
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	38	13
Tradjenta	Linagliptin	38	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	37	suppressed
Alendronate Sodium	Alendronate Sodium	35	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	35	16
Zolpidem Tartrate	Zolpidem Tartrate	35	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	34	11
Breo Ellipta	Fluticasone/Vilanterol	33	suppressed
Meclizine Hcl	Meclizine Hcl	33	15
Spironolactone	Spironolactone	33	13
Entresto	Sacubitril/Valsartan	32	suppressed
Ondansetron Hcl	Ondansetron Hcl	31	25
Pioglitazone Hcl	Pioglitazone Hcl	31	suppressed
Valsartan	Valsartan	31	suppressed
Ibandronate Sodium	Ibandronate Sodium	30	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	30	suppressed
Tresiba Flextouch U-200	Insulin Degludec	30	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	29	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	29	suppressed
Risedronate Sodium	Risedronate Sodium	29	11
Nystatin	Nystatin	28	13
Albuterol Sulfate	Albuterol Sulfate	26	suppressed
Amlodipine-Valsartan-Hctz	Amlodipine/Valsartan/Hcthiazid	25	suppressed
Belsomra	Suvorexant	25	suppressed
Lactulose	Lactulose	25	suppressed
Methylprednisolone	Methylprednisolone	24	21
Trulicity	Dulaglutide	24	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	23	suppressed
Rybelsus	Semaglutide	23	suppressed
Dexlansoprazole Dr	Dexlansoprazole	22	suppressed
Humalog Kwikpen U-100	Insulin Lispro	22	suppressed
Memantine Hcl Er	Memantine Hcl	22	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	21	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	21	suppressed
Nystop	Nystatin	21	suppressed
Pravastatin Sodium	Pravastatin Sodium	21	suppressed
Citalopram Hbr	Citalopram Hydrobromide	20	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	20	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	19	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	19	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	18	suppressed
Eszopiclone	Eszopiclone	18	suppressed
Ezetimibe	Ezetimibe	18	suppressed
Lamotrigine	Lamotrigine	18	suppressed
Myrbetriq	Mirabegron	18	suppressed
Prednisone	Prednisone	18	suppressed
Trazodone Hcl	Trazodone Hcl	18	suppressed
Trintellix	Vortioxetine Hydrobromide	18	suppressed
Xarelto	Rivaroxaban	18	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	17	suppressed
Digoxin	Digoxin	17	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	17	suppressed
Lovastatin	Lovastatin	17	suppressed
Novolin R	Insulin Regular, Human	17	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	17	17
Carbidopa-Levodopa	Carbidopa/Levodopa	16	suppressed
Cephalexin	Cephalexin	16	12
Promethazine Hcl	Promethazine Hcl	16	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	16	suppressed
Cinacalcet Hcl	Cinacalcet Hcl	15	suppressed
Galantamine Hbr	Galantamine Hbr	15	suppressed
Humalog	Insulin Lispro	15	suppressed
Telmisartan	Telmisartan	15	suppressed
Finasteride	Finasteride	14	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	14	suppressed
Paroxetine Hcl	Paroxetine Hcl	14	suppressed
Rivastigmine	Rivastigmine	14	suppressed
Valacyclovir	Valacyclovir Hcl	14	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	13	suppressed
Clonidine Hcl	Clonidine Hcl	13	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	13	suppressed
Felodipine Er	Felodipine	13	suppressed
Oxaprozin	Oxaprozin	13	suppressed
Sertraline Hcl	Sertraline Hcl	13	suppressed
Terazosin Hcl	Terazosin Hcl	13	suppressed
Tramadol Hcl-Acetaminophen	Tramadol Hcl/Acetaminophen	13	suppressed
Cilostazol	Cilostazol	12	suppressed
Kerendia	Finerenone	12	suppressed
Ropinirole Hcl	Ropinirole Hcl	12	suppressed
Tresiba Flextouch U-100	Insulin Degludec	12	suppressed
Trijardy Xr	Empaglifloz/Linaglip/Metformin	12	suppressed
Acyclovir	Acyclovir	11	suppressed
Baclofen	Baclofen	11	suppressed
Colchicine	Colchicine	11	suppressed
Fiasp Flextouch	Insulin Aspart (Niacinamide)	11	suppressed
Midodrine Hcl	Midodrine Hcl	11	suppressed
Risperidone	Risperidone	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error